Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention
- 9 September 2010
- journal article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 25 (4) , 528-533
Abstract
The prevalence of statin use is high but adherence low. For public health intervention to be rational, subpopulations of nonadherent subjects must be defined. To categorise statin users with respect to patterns of reimbursement, this study was performed using the main French health reimbursement database for the Aquitaine region of south-western France. The cohort included subjects who submitted a reimbursement for at least one delivery of a statin (index) during the inclusion period (1st of September 2004-31st of December 2004). Indicators of adherence from reimbursement data were considered for principal component analysis. The 119,570 subjects included and analysed had a sex ratio of 1.1, mean (SD) age of 65.9 (11.9), and 13% were considered incident statin users. Principal component analysis found three dimensions that explained 67% of the variance. Using a K-means classification combined with a hierarchical ascendant classification, six groups were characterised. One group was considered nonadherent (10% of study population) and one group least adherent (1%). This novel application of principal component analysis identified groups that may be potential targets for intervention. The least adherent group appears to be one of the most appropriate because of both its relatively small size for case review with prescribing physicians and its very poor adherence.Keywords
This publication has 23 references indexed in Scilit:
- Pharmacoepidemiological research using French reimbursement databases: yes we can!Pharmacoepidemiology and Drug Safety, 2010
- Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAmerican Heart Journal, 2008
- Long-term persistence with statin therapy: A nationwide register study in FinlandClinical Therapeutics, 2008
- Persistence and adherence to cholesterol lowering agents: Evidence from Régie de l'Assurance Maladie du Québec dataAmerican Heart Journal, 2006
- Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort studyEuropean Heart Journal, 2006
- Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trialsBMJ, 2005
- Persistence and determinants of statin therapy among middle‐aged patients for primary and secondary preventionBritish Journal of Clinical Pharmacology, 2005
- Differences between clinical trials and postmarketing useBritish Journal of Clinical Pharmacology, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998